Drug intelligence / Profile preview

racemethionine

Development stage
Unknown
Lead developer
Evonik
Modality
Small Molecules
Administration
Oral
01

Overview

Racemethionine is the racemic mixture of the essential sulfur-containing amino acid methionine (DL-methionine). It is primarily utilized as a urinary acidifier to reduce the pH of urine, which helps control the formation of ammonia. This action is clinically applied to manage ammonia-induced diaper rash in infants and to control odor and skin irritation in incontinent adults. Additionally, it serves as a metabolic precursor for cysteine and glutathione, playing a role in detoxification processes and sulfur metabolism. While historically used in the management of liver disorders and acetaminophen overdose, its primary contemporary pharmaceutical use is for urinary pH regulation. Recent research has also identified racemethionine as a potential biomarker for oxaliplatin-induced peripheral neuropathy and as a metabolite involved in high-altitude adaptation in animal models.

Brand names
PedamethM-CapsUracidOdor-Scrip
Other names
DL-methionineDL-2-Amino-4-(methylthio)butanoic acidracemethionine

Beyond the preview

Go deeper on racemethionine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on racemethionine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call